Clonality in haematopoietic stem cell ageing

Mech Ageing Dev. 2020 Jul:189:111279. doi: 10.1016/j.mad.2020.111279. Epub 2020 Jun 8.

Abstract

Clonal haematopoiesis of indeterminate potential (CHIP) is widespread in the elderly. CHIP is driven by somatic mutations in leukaemia driver genes, such as Janus Kinase 2 (JAK2), Tet methylcytosine dioxygenase 2 (TET2), ASXL Transcriptional Regulator 1 (ASXL1) and DNA (cytosine-5)-methyltransferase 3A (DNMT3A), leading to reduced diversity of the blood pool. CHIP carries an increased risk for leukaemia and cardiovascular disease. Apart from mutations driving CHIP, environmental factors such as chemokines and cytokines have been implicated in age-dependent multimorbidities associated with CHIP. However, the mechanism of CHIP onset and the relationship with environmental and cell-intrinsic factors remain poorly understood. Here we contrast cell-intrinsic and environmental factors involved in CHIP development and disease propagation.

Keywords: Ageing; Cell-Intrinsic; Clonal haematopoiesis of indeterminate potential; DNMT3A; Environment; TET2.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging / metabolism*
  • Aging / pathology
  • Animals
  • Cellular Senescence*
  • Cytokines / metabolism
  • DNA (Cytosine-5-)-Methyltransferases / metabolism
  • DNA Methyltransferase 3A
  • DNA-Binding Proteins / metabolism
  • Dioxygenases
  • Hematopoiesis*
  • Hematopoietic Stem Cells / metabolism*
  • Hematopoietic Stem Cells / pathology
  • Humans
  • Janus Kinase 2 / metabolism
  • Proto-Oncogene Proteins / metabolism
  • Repressor Proteins / metabolism
  • Signal Transduction*

Substances

  • ASXL1 protein, human
  • Cytokines
  • DNA-Binding Proteins
  • DNMT3A protein, human
  • Proto-Oncogene Proteins
  • Repressor Proteins
  • Dioxygenases
  • TET2 protein, human
  • DNA (Cytosine-5-)-Methyltransferases
  • DNA Methyltransferase 3A
  • JAK2 protein, human
  • Janus Kinase 2